An investigation on behalf of current long-term investors in shares of C.R. Bard, Inc. (NYSE:BCR) over potential wrongdoing was announced and current NYSE:BCR investors, who hold their shares for years, should contact the Shareholders Foundation at firstname.lastname@example.org
San Diego, CA -- (SBWIRE) -- 05/21/2013 -- An investigation on behalf of current investors, who purchased their NYSE:BCR shares as early as 1998 or earlier, was announced concerning whether certain officers and directors of C.R. Bard, Inc. potentially breached their fiduciary duties.
Investors who purchased shares of C.R. Bard, Inc. (NYSE:BCR) several years ago and hold any of those shares, have certain options and should contact the Shareholders Foundation at mail(at)shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain C.R. Bard officers and directors breached their fiduciary duties and caused damage to the company and its shareholders by, among other things, failing to implement adequate internal controls.
In November 2006, C.R. Bard, Inc. received a subpoena issued by the U.S. Department of Health and Human Services, Office of Inspector General, under the authority of the federal healthcare fraud and false claims statutes, seeking documents related to the company’s brachytherapy business. On January 27, 2012, C.R. Bard, Inc. announced that it had reached a preliminary agreement with the civil and criminal divisions of the United States Attorney’s Office for the Northern District of Georgia to resolve claims with respect to the Brachytherapy Matter.
C.R. Bard, Inc. reported that its annual Total Revenue rose from over $2.53 billion in 2009 to over $2.95 billion in 2012 and its respective Net Income increased from $460.10 million to $530.10 million.
Shares of C.R. Bard, Inc. (NYSE:BCR) grew from slightly under $71 per share in May 2009 to as high as almost $113 in July 2011 but fell in the second half of 2011 to almost $83 per share.
On May 20, 2013, NYSE:BCR shares closed at $106.97 per share.
Those who purchased shares of C.R. Bard, Inc. (NYSE:BCR), have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego